ArticleBMC infectious diseases2026
Time to viral load suppression after enhanced adherence counseling among HIV patients attending antiretroviral therapy in Southwest Ethiopia.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEnhanced adherence counseling (EAC) is given to patients with high viral loads (over 1000 copies/ml) to improve Antiretroviral Therapy (ART) adherence, with sessions occurring monthly for three months. A follow-up viral load test is conducted afterwards, but there is a lack of evidence on the impact of EAC on viral load reduction, highlighting the need for further research.
objectiveThis study aimed to assess the time to viral load suppression and its predictors among clients receiving EAC at Mattu Karl Comprehensive Specialized Hospital and public hospitals in Gambella town, southwest Ethiopia, 2024.
methodsA retrospective follow-up study was conducted among 403 randomly selected patients on EAC at Gambella town hospitals and Mettu Karl Comprehensive Specialized Hospital from January 2019 to December 2023. Data were extracted from patient records and analyzed using STATA. Both bivariate and multivariable survival models were used, with a Cox proportional hazard model to identify predictors for viral load suppression. A p-value < 0.05 was considered statistically significant.
resultsThe incidence density rate of viral load non-suppression among ART-attending patients was 12.19 (95% CI: 10.9–13.6) per 100 person-months. In the multivariable survival analysis, participants who received Cotrimoxazole Preventive Therapy(CPT) (adjusted HR = 1.55 (95% CI: 1.0–2.3)), disclosed their HIV status (adjusted HR = 1.62 (95% CI: 1.1–2.3)), had fair adherence to ART (adjusted HR = 1.8 (95% CI: 1.1–3.1)), and had no opportunistic infections (adjusted HR = 2.13 (95% CI: 1.3–6.1)) were independent predictors of viral load suppression.
conclusionThe study found a lower median time to viral load suppression compared to previous Ethiopian studies. Key predictors of suppression included receiving CPT, disclosing HIV status, adhering to ART, and not having opportunistic infections. Emphasis should be placed on providing CPT, encouraging status disclosure, and improving opportunistic infection management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.